Document is current
Any future updates will be listed below
-
Authors
Klerk-Bos, Kim-Lara https://orcid.org/0009-0001-1557-3958
Hennus, Marije P. https://orcid.org/0000-0003-1508-0456
Ehlert, Marco https://orcid.org/0009-0006-3786-2116
Kluijtmans, Manon https://orcid.org/0000-0001-6601-7639
Egberts, Toine C. G. https://orcid.org/0000-0003-1758-7779
Wilting, Ingeborg https://orcid.org/0000-0001-9173-4840
- License Information
-
More Information
Article History
Received: 13 March 2026
Accepted: 11 April 2026
First Online: 8 May 2026
Declarations
:
: The authors declare no competing interests.
: The study was approved on October 10th, 2024, by the Institutional Review Board (IRB) affiliated with the Department of Pharmacoepidemiology & Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University. (nr. UPF 2415).
: Written informed consent was obtained from all participants.
